D.C. Week: Two Novel Opioids Win Tepid Backing From FDA Panel

(MedPage Today) -- Also, a House subcommittee contemplates ACA revisions
via D.C. Week: Two Novel Opioids Win Tepid Backing From FDA Panel
by